AbuAlrob MA, Hussein A, Abdellatif R, Itbaisha A, Zammar K, Mesraoua B (2025) Seizure recurrence after GLP1 receptor agonist initiation in adults with epilepsy
Aesthetics in Troy
Any platform prescribing these drugs should screen for these, and any patient with these conditions should not receive compounded or brand-name GLP-1 therapy
Despite advances in chemotherapy, radiotherapy, and targeted therapies, challenges such as poor drug accumulation, systemic toxicity, and multidrug resistance persist, partly due to elevated intracellular GSH levels that neutralize reactive therapeutics and reduce treatment response
Are there side effects I should expect with semaglutide injections